Advocacy claim & public demand. MAHA rates EMF harms to children “low–inadequate” and omits convergent evidence from WHO‑commissioned reviews, NTP, and Ramazzini.
HHS is bound by PL 90‑602 to run a continuous control program and prescribe performance standards when needed.
This page documents omissions, the core mechanism, and demands a formal correction, an NTP restart, and child‑first protections.
What Public Law 90‑602 requires
“The Secretary shall establish and carry out an electronic product radiation control program …; as part of such program, [he] shall plan, conduct, coordinate, and support research … to minimize emissions and exposure.” 21 U.S.C. § 360ii.
“The Secretary shall by regulation prescribe performance standards for electronic products … when necessary for the protection of the public health and safety.” 21 U.S.C. § 360kk.
What MAHA said vs. what the science shows
MAHA devoted roughly a paragraph to EMF and graded harms to children as “low–inadequate.” That stance collapses under the evidence MAHA left out:
| Milestone | Finding | MAHA treatment |
|---|---|---|
| NTP 2‑year bioassay (2018) | Clear evidence of malignant heart schwannomas & signals for brain gliomas; non‑linear dose signals. | Downgraded as “needs more research.” |
| Ramazzini lifetime study (2018) | Same tumor types at tower‑level fields (~0.1 W/kg), converging with NTP. | Not cited. |
| WHO cancer review (Mevissen 2025) | High certainty for gliomas & cardiac schwannomas in animals at realistic SARs. | Not cited. |
| WHO fertility review (2024; corrigendum 2025) | Detrimental effects: failed pregnancies ↑; sperm DNA damage ↑. | Not cited. |
NTP’s “dose‑inversion” signal
- GSM male‑rat brain lesions peaked at 1.5 W/kg (e.g., malignant gliomas 3 at 1.5 vs 2 at 6.0).
- Non‑monotonic biology is real; MAHA ignored it and repeated the “only heating matters” narrative.
Proof that RFR‑induced oxidative stress scales with mitochondrial and VGIC (S4) density
In short, S4‑gating‑driven bioelectric mistiming is an upstream initiator of mitochondrial stress and ROS overproduction, causing oxidative stress and macro damage in tissues with the highest S4 helix and mitochondria density—nerve and heart. Summary based on your post.
Durdík et al. (2019) — cord blood gradient shows ROS tracks differentiation
- 2.14 GHz exposure at ~0.2 W/kg for 1 h increased ROS across subpopulations; effect was transient by 3 h.
- Most critical finding: “ROS rises with the higher degree of cellular differentiation.”
- Interpretation: mature cells have more mitochondria and express more VGICs with S4 voltage sensors—prime targets for EMF‑driven dysregulation.
Ion Forced Oscillation (IFO) model — Panagopoulos (2025)
- Low‑intensity oscillating EMFs drive nearby free ions to oscillate; their Coulomb forces act on the S4 helix, mimicking ~30 mV shifts—enough to trigger/inhibit gating.
- Consequences: inappropriate channel opening, Ca²⁺ hyperactivation, mitochondrial depolarization, superoxide surge, and apoptosis/DNA damage risk.
- Mechanism is non‑thermal, coherent, and field‑driven—consistent with observed non‑monotonic biology.
Myth check: “Microwave photons are too weak”
- IFO relies on classical electrostatic forces on S4—not photonic ionization. Picometer‑scale ion displacement near the membrane can reach gating‑level forces.
- Result: pulsed fields can “pick the lock” of VGICs without heating, initiating a Ca²⁺/ROS feedback loop.
Why some tissues are hit hardest
- Neural tissue: extreme VGIC density + high mitochondrial demand → gliomas, cognitive/behavioral endpoints.
- Cardiac tissue: cardiomyocytes ~⅓ mitochondria by volume; conduction system depends on precise gating → cardiac schwannomas/arrhythmia endpoints.
- Reproductive tissue: sensitive to Ca²⁺/redox → fertility, sperm DNA damage, pregnancy outcomes.
Policy implications
- Thermal‑only SAR limits ignore non‑thermal S4/VGIC‑mitochondria mechanisms; they’re not protective for children/pregnancy.
- Chronic, low‑intensity exposure is biologically active at SARs far below current ceilings (e.g., ~0.2 W/kg in Durdík).
- Standards must address modulation, duty‑cycle, peak structure, and cumulative dose—with pediatric default factors.
Demand correction — today
What to demand (copy these asks)
- Issue a MAHA erratum + technical annex including WHO 2024–2025, NTP, Ramazzini, sponsorship‑bias literature, and the S4/VGIC‑mitochondria mechanism; explain non‑monotonic biology plainly.
- Restart and expand NTP’s RF program with preregistration, independent governance, and open data.
- Enforce PL 90‑602: HHS to lead risk assessment and propose RF performance standards for consumer electronics (modulation, duty‑cycle, peaks, cumulative exposure, pediatric factors).
- Pediatric RF Task Force (HHS/EPA/FCC/DOE/ED): deliver a six‑month roadmap for long‑term exposure, mechanisms, and modern usage.
- Li‑Fi‑first indoors for schools/childcare with procurement/spec guidance to cut ambient RF while protections modernize.
Talking points (for calls & emails)
- It’s been {{DAYS}} days since MAHA was released—without correcting omissions.
- MAHA ignored WHO 2025 cancer + 2024–2025 fertility reviews, downplayed NTP, omitted Ramazzini, and missed the S4/VGIC–mitochondria mechanism.
- PL 90‑602 requires continuous research and standards when needed—HHS must act.
- Protect kids now with Li‑Fi‑first indoors and a child‑first roadmap.
30‑second call script
Hi, I’m asking you to correct the MAHA report on wireless risks.
It’s been {{DAYS}} days since release. MAHA ignored WHO 2025 and 2024–2025 fertility reviews,
downplayed NTP, omitted Ramazzini, and missed the S4/VGIC–mitochondria mechanism.
Public Law 90‑602 requires HHS to run research and set standards.
Please: (1) issue a MAHA erratum + annex, (2) restart NTP with open data,
and (3) publish a Li‑Fi‑first advisory and a pediatric roadmap within six months.
Email / letter text
Subject: Correct MAHA now — enforce Public Law 90‑602; restart NTP; Li‑Fi‑first for schools
MAHA (May 22, 2025) gave EMF a brief treatment and rated harms to children “low–inadequate.”
It ignored WHO‑commissioned reviews (2024–2025), downplayed NTP 2018, omitted Ramazzini 2018,
and failed to explain non‑thermal mechanisms including S4/VGIC‑driven Ca²⁺ mis‑signaling and mitochondrial ROS.
Requests:
• Issue a MAHA erratum + technical annex that incorporates WHO 2024–2025, NTP/Ramazzini, sponsorship‑bias literature, and the S4/VGIC–mitochondria mechanism.
• Restart and expand NTP’s RF program with preregistration, independent governance, and open data.
• Enforce PL 90‑602 by leading federal risk assessment and proposing RF performance standards.
• Issue a Li‑Fi‑first advisory for schools/childcare with procurement/spec guidance while updated protections are finalized.
It has been {{DAYS}} days since release. Please correct the record and protect children now.
Briefing materials (tap to expand & copy)
MAHA Briefing Memo — statutory duties & fast, durable plan
[Condensed]
• HHS duties: 21 U.S.C. §§ 360ii, 360kk — continuous program; performance standards when needed.
• EHT v. FCC (2021): remand for failure to address non‑thermal/long‑term/child‑specific risks; HHS science is essential to cure the record.
• 90–180 days: restart NTP; HHS NPRM for RF performance standards; Interagency RF Working Group; RF Risk Summary for clinicians/schools; Li‑Fi‑first advisory.
• Legislative pair: targeted § 704 fix to allow local implementation of HHS standards; appropriations for NTP/test facilities.
• Defensibility: statute‑first; record‑cure; integrates WHO 2024–2025 + NTP/Ramazzini; transparent milestones & open data.
Letter to HHS — correcting MAHA & launching Li‑Fi‑first
[Condensed]
Dear Secretary Kennedy,
MAHA’s RF section relies on pre‑2023 sources and omits WHO‑program reviews (2024–2025). It downgrades NTP, ignores Ramazzini, and overlooks sponsorship bias.
Please enforce PL 90‑602 by restarting NTP, leading a de novo risk assessment, proposing HHS performance standards, and issuing a national Li‑Fi‑first advisory for schools.
A 100‑school Li‑Fi demonstration should begin now, expanding to 1,000. Parents cannot wait.
Sincerely,
[Your name]
References & receipts
- Public Law 90‑602 (1968) — program & standards duties (21 U.S.C. §§ 360ii, 360kk).
- NTP (2018) final reports — clear evidence for malignant heart schwannomas; some for gliomas.
- Ramazzini (2018) — similar tumor types at tower‑level exposures (~0.1 W/kg).
- WHO‑program cancer SR (2025) — high certainty for glioma & cardiac schwannoma in animals.
- WHO fertility SR (2024; 2025 corrigendum) — detrimental effects on pregnancy success & sperm DNA.
- Durdík et al. (2019) — cord blood differentiation gradient; ROS scales with differentiation at ~0.2 W/kg.
- Panagopoulos (2025) IFO model — ionic oscillation drives S4 gating‑level forces (non‑thermal).
- EHT v. FCC (D.C. Cir. 2021) — remand for failure to address non‑thermal/long‑term/child‑specific harms.
This advocacy page asserts that MAHA’s handling of RF risks is incomplete and inconsistent with Public Law 90‑602. For legal advice specific to you, consult an attorney.